Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Total 13F shares
-
54,774,480
-
Share change
-
-1,526,272
-
Total reported value
-
$1,002,337,337
-
Put/Call ratio
-
48%
-
Price per share
-
$18.30
-
Number of holders
-
118
-
Value change
-
-$29,154,494
-
Number of buys
-
54
-
Number of sells
-
42
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q4 2022
As of 31 Dec 2022 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) had 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 54,774,480 shares of stock of the company.
Largest 10 holders included DRIEHAUS CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., BRAIDWELL LP, ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, and STATE STREET CORP.
This table shows 120 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.